NYSE American · Medical Devices · USD

Picard Medical, Inc. (PMI) Stock Analysis

Picard Medical, Inc. (PMI) is a Medical Devices stock listed on NYSE American and quoted in US Dollar.

Last Updated: October 21, 2026

PMI

$9.63

−$0.85 (−8.11%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare PMI with… →

PMI Key Statistics

As of Oct 21, 2026

Trading

Open: $11.01
Previous Close: $10.48
Day's Range: 9.18–11.06
52-Week Range: 2.65–684.00
Volume: 420.38K

Valuation

Market Cap: $22.52M
P/E Ratio: unprofitable
P/S ratio: 3.57
EPS (ttm): −6.93

Financials (FY)

Revenue (FY): $4.94M+12.50%
Net Income (FY): −$27.00M
Shares Outstanding: 2.34M
1-Year Return: −98.48%

Dividend and dates

Avg Volume: 1.62M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, PMI closed at $9.63, −98.48% over 1 year.

Picard Medical, Inc. (PMI) has a market capitalization of $22.52M.

In fiscal 2025, PMI reported revenue of $4.94M.

PMI Stock Return by Calendar Year

Picard Medical, Inc. (PMI) return since Aug 2025: what $10,000 became

1 year: $10,000 $152; −98.48%
Since Aug 2025: $10,000 $420; −95.80%

If you had invested $10,000 in Picard Medical, Inc. (PMI) at the close on August 29, 2025, the earliest close on record here, it would have been worth $420 at the close on October 21, 2026: −95.80% in total, −93.74% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

Year	Return
2026 (partial year)	−88.99%
2025 (partial year)	−61.87%

As of October 21, 2026.

PMI Revenue and Earnings by Fiscal Year

FY ends December

RevenueNet income

2022202320242025

Fiscal year	Revenue	Net income	Net margin
2025	$4.94M	−$27.00M	−546.6%
2024	$4.39M	−$21.06M	−479.5%
2023	$5.04M	−$15.57M	−308.7%
2022	$4.11M	−$11.17M	−271.5%

Fiscal year	Revenue	Gross profit	Operating income	Net income	Net margin
2025	$4.94M	−$204.00K	−$13.26M	−$27.00M	−546.6%
2024	$4.39M	−$112.00K	−$13.71M	−$21.06M	−479.5%
2023	$5.04M	−$2.31M	−$15.50M	−$15.57M	−308.7%
2022	$4.11M	−$4.99M	−$11.07M	−$11.17M	−271.5%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

PMI Valuation vs Medical Devices Median

Median of 145 stocks

Metric	PMI	Medical Devices median	vs median
P/S ratio	3.57	2.53	41% above

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Picard Medical, Inc. (PMI) is capitalised at $22.52M on the latest close. It is classified in the Medical Devices industry, within the Healthcare sector. The company reports 75 employees.

PMI last closed at $9.63 on October 21, 2026. That is −$0.85 (−8.11%) against the previous close. The 52-week range on file runs from $2.65 to $684.00. The latest close sits 263.12% above that 52-week low.

Financial Health

In fiscal 2025, Picard Medical, Inc. reported revenue of $4.94M. Against the prior fiscal year total of $4.39M, that is a change of +12.50%. The same year closed with a net loss of $27.00M. Earnings per share on a trailing basis come to −6.93.

Across the 4 fiscal years on file, revenue moves from $4.11M in 2022 to $4.94M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

The record shows negative trailing earnings, so no price-to-earnings ratio is published. Measured against sales, the shares trade at 3.57 times revenue. On price-to-sales that is 41.31% above the Medical Devices median of 2.53. The medians here are taken across 145 Medical Devices companies that report the metric.

Over the trailing twelve months the total return is −98.48%. Daily returns over the trailing 1 year annualize to a volatility of 231.77%.

Growth & Income

The record shows no dividend for PMI.

2026 is still running; the total return is −88.99% year to date.

Peer Comparison

Picard Medical, Inc. (PMI) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company	Ticker	Market Cap	P/E Ratio
Picard Medical, Inc.	PMI	$22.52M	—
Abbott Laboratories	ABT	$173.92B	32.4
Medtronic plc.	MDT	$119.00B	22.9
Stryker Corporation	SYK	$114.15B	30.8

The Medical Devices industry average P/E ratio is 27.1x. Picard Medical, Inc. has no P/E ratio because it is not currently profitable.

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

MDT

Medtronic plc.

$119.00B

SYK

Stryker Corporation

$114.15B

BSX

Boston Scientific Corporation

$64.33B

Edwards Lifesciences Corporation

$50.95B

GEHC

GE HealthCare Technologies Inc.

$31.17B

View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

JNJ

Johnson & Johnson

$621.22B

ABBV

AbbVie Inc.

$503.27B

UNH

UnitedHealth Group Incorporated

$374.30B

MRK

Merck & Co., Inc.

$369.78B

View all Healthcare stocks →

About Picard Medical, Inc.

Picard Medical, Inc., together with its subsidiaries, engages in the designing, manufacturing, production, supply, marketing, and sale of medical device products. The company offers SynCardia TAH, an artificial heart for patients that is designed to function as a failed human heart in patients suffering from advanced heart failure. The company operates in the United States, Europe, and internationally. The company was incorporated in 2021 and is headquartered in Tucson, Arizona. Picard Medical, Inc. operates as a subsidiary of Hunniwell Picard I, Llc.

Visit website →